The concept of innovative drugs rebounds, BHC and HWHG hit the limit up
The innovative drug concept rebounded. As of the time of publication, BHC and HWHG hit the daily limit, while Boteng Co., Ltd., Rejing Biotech, and Heng Rui Medicine saw significant gains
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments